BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8174801)

  • 1. Photo-inactivation of viruses in therapeutical plasma.
    Mohr H; Lambrecht B; Schmitt H
    Dev Biol Stand; 1993; 81():177-83. PubMed ID: 8174801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimizing parameters in photodynamic virus inactivation of fresh frozen plasma].
    Mohr H; Lambrecht B; Schmitt H
    Beitr Infusionsther; 1993; 31():25-30. PubMed ID: 7693260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methylene blue/light treatment of virus inactivated human plasma: production and clinical experience].
    Mohr H; Pohl U; Lambrecht B; Wieding JU; Schmitt H
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():19-24. PubMed ID: 8374283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
    Mohr H; Knüver-Hopf J; Gravemann U; Redecker-Klein A; Müller TH
    Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AIPc) sulfonates.
    Horowitz B; Rywkin S; Margolis-Nunno H; Williams B; Geacintov N; Prince AM; Pascual D; Ragno G; Valeri CR; Huima-Byron T
    Blood Cells; 1992; 18(1):141-9; discussion 150. PubMed ID: 1617188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid inactivation of HIV-1 in single donor preparations of human fresh frozen plasma by methylene blue/light treatment.
    Lambrecht B; Norley SG; Kurth R; Mohr H
    Biologicals; 1994 Sep; 22(3):227-31. PubMed ID: 7811456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of viruses with photoactive compounds.
    Matthews JL; Sogandares-Bernal F; Judy M; Gulliya K; Newman J; Chanh T; Marengo-Rowe A
    Blood Cells; 1992; 18(1):75-88; discussion 88-9. PubMed ID: 1617195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing virus inactivation and retention of platelet properties following treatment with aminomethyltrimethylpsoralen and ultraviolet A light.
    Moroff G; Wagner S; Benade L; Dodd RY
    Blood Cells; 1992; 18(1):43-54; discussion 54-6. PubMed ID: 1617192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two viral inactivation methods on platelets: laser-UV radiation and merocyanine 540-mediated photoinactivation.
    Prodouz KN; Lytle CD; Bonner RF; Fratantoni JC
    Blood Cells; 1992; 18(1):101-14; discussion 114-6. PubMed ID: 1617186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merocyanine-sensitized photoinactivation of enveloped viruses.
    Sieber F; O'Brien JM; Gaffney DK
    Blood Cells; 1992; 18(1):117-27; discussion 128. PubMed ID: 1617187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic inactivation of enveloped viruses: potential application for blood banking.
    Judy MM
    J Clin Laser Med Surg; 1990 Aug; 8(4):49-52. PubMed ID: 10149001
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral inactivation in blood and red cell concentrates with benzoporphyrin derivative.
    North J; Neyndorff H; King D; Levy JG
    Blood Cells; 1992; 18(1):129-39; discussion 139-40. PubMed ID: 1319771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical inactivation of viruses and bacteriophage in plasma and plasma fractions.
    Morel P; Lin L; Wiesehahn G; Corash L
    Blood Cells; 1992; 18(1):27-41; Discussion 41-2. PubMed ID: 1617190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma proteins.
    Wang D; Bu F; Xu J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):52-5. PubMed ID: 11503026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus inactivation in blood components by photoactive phenothiazine dyes.
    Wagner SJ
    Transfus Med Rev; 2002 Jan; 16(1):61-6. PubMed ID: 11788930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus inactivated single-donor fresh plasma preparations.
    Mohr H; Lambrecht B; Knuever-Hopf J
    Infusionsther Transfusionsmed; 1992 Apr; 19(2):79-83. PubMed ID: 1623324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas).
    Pock K; Heger A; Janisch S; Svae TE; Römisch J
    Transfus Apher Sci; 2007 Dec; 37(3):223-31. PubMed ID: 18006380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial experiences with methylene blue virus inactivated fresh frozen plasma: results of a clinical and in vitro study].
    Wieding JU; Neumeyer H
    Infusionsther Transfusionsmed; 1992 Apr; 19(2):84-90. PubMed ID: 1623325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for fresh frozen plasma: evaluation of virus inactivating preparations].
    Pindur G; Kiesewetter H; Seyfert UT; Wenzel E
    Beitr Infusionsther; 1993; 31():74-80. PubMed ID: 7693268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Virus inactivation of plasma].
    Schmitt H; Mohr H; Lambrecht B; Knüver-Hopf J
    Beitr Infusionsther; 1991; 28():82-91. PubMed ID: 1725665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.